Lista de obras - Elisabetta Rovida - Dominio Público Uruguay

AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia ⬇️

artículo científico publicado el 14 de marzo de 2013

Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma

artículo científico publicado en 2019

Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy

artículo científico publicado en 2020

Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts.

artículo científico publicado en 2003

CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells

artículo científico publicado en 2019

Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells

artículo científico publicado en 2013

Chronic Myeloid Leukemia and Hepatoblastoma: Two Cancer Models to Link Metabolism to Stem Cells

artículo científico publicado en 2016

Constitutive activation of the MAPK pathway mediates v-fes-induced mitogenesis in murine macrophages.

artículo científico publicado en 2000

Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction

artículo científico publicado en 2016

ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells

artículo científico publicado en 2007

ERK5 is activated by oncogenic BRAF and promotes melanoma growth

artículo científico publicado en 2018

ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion.

artículo científico publicado en 2008

Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma

artículo científico publicado en 2020

Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway.

artículo científico publicado en 2016

Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia

artículo científico publicado en 2011

Hypoxia suppresses BCR/Abl and selects imatinib-insensitive progenitors within clonal CML populations

artículo científico publicado en 2006

Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.

artículo científico publicado en 2015

Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets

artículo científico publicado en 2013

INTERLEUKIN 2 DOWN-MODULATES THE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR IN MURINE MACROPHAGES

artículo científico publicado en 1996

Impact of ERK5 on the Hallmarks of Cancer ⬇️

artículo científico publicado en 2019

In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features

artículo científico publicado en 2020

Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors

artículo científico publicado en 2000

Interleukin-4 rapidly down-modulates the macrophage colony-stimulating factor receptor in murine macrophages.

artículo científico publicado en 1996

Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities

artículo científico

Low-dose methotrexate enhances cycling of highly anaplastic cancer cells

artículo científico publicado en 2016

Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?

artículo científico

One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a "hypoxic" environment

artículo científico publicado en 2014

Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages

artículo científico publicado en 2002

Possible mechanisms and function of nuclear trafficking of the colony-stimulating factor-1 receptor.

artículo científico publicado en 2014

Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2.

artículo científico publicado en 2015

Salarin C inhibits the maintenance of chronic myeloid leukemia progenitor cells.

artículo científico publicado en 2015

Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells

artículo científico publicado en 2007

Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells.

artículo científico publicado en 2007

TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation.

artículo científico publicado en 2001

Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.

artículo científico publicado en 2017

Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells

The Culture-Repopulating Ability assays and incubation in low oxygen: a simple way to test drugs on leukaemia stem or progenitor cells.

artículo científico publicado en 2013

The Leukemic Stem Cell Niche: Adaptation to "Hypoxia" versus Oncogene Addiction

artículo científico publicado en 2017

The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines

artículo científico publicado en 2011

The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents

artículo científico publicado en 2015

The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability

scientific article published on 01 April 2000

The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming

artículo científico publicado en 2012

The low-molecular-weight phosphotyrosine protein phosphatase, when overexpressed, reduces the mitogenic response to macrophage colony-stimulating factor and tyrosine phosphorylation of its receptor.

artículo científico publicado en 1998

The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy.

artículo científico publicado en 2014

The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma.

artículo científico publicado en 2014

The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells

artículo científico publicado en 2019

Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells ⬇️

artículo científico publicado el 15 de enero de 2013

Tryptophan availability selectively limits NO-synthase induction in macrophages.

artículo científico publicado en 2003

p38 and cancer: Yang gets Yin

artículo científico publicado en 2008

Lista de obras de Elisabetta Rovida

AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia ⬇️

Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma

Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy

Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts.

CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells

Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells

Chronic Myeloid Leukemia and Hepatoblastoma: Two Cancer Models to Link Metabolism to Stem Cells

Constitutive activation of the MAPK pathway mediates v-fes-induced mitogenesis in murine macrophages.

Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction

ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells

ERK5 is activated by oncogenic BRAF and promotes melanoma growth

ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion.

Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma

Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway.

Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia

Hypoxia suppresses BCR/Abl and selects imatinib-insensitive progenitors within clonal CML populations

Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.

Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets

INTERLEUKIN 2 DOWN-MODULATES THE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR IN MURINE MACROPHAGES

Impact of ERK5 on the Hallmarks of Cancer ⬇️

In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features

Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors

Interleukin-4 rapidly down-modulates the macrophage colony-stimulating factor receptor in murine macrophages.

Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities

Low-dose methotrexate enhances cycling of highly anaplastic cancer cells

Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?

One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a "hypoxic" environment

Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages

Possible mechanisms and function of nuclear trafficking of the colony-stimulating factor-1 receptor.

Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2.

Salarin C inhibits the maintenance of chronic myeloid leukemia progenitor cells.

Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells

Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells.

TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation.

Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.

Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells

The Culture-Repopulating Ability assays and incubation in low oxygen: a simple way to test drugs on leukaemia stem or progenitor cells.

The Leukemic Stem Cell Niche: Adaptation to "Hypoxia" versus Oncogene Addiction

The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines

The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents

The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability

The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming

The low-molecular-weight phosphotyrosine protein phosphatase, when overexpressed, reduces the mitogenic response to macrophage colony-stimulating factor and tyrosine phosphorylation of its receptor.

The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy.

The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma.

The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells

Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells ⬇️

Tryptophan availability selectively limits NO-synthase induction in macrophages.

p38 and cancer: Yang gets Yin